Date |
Research Question / Title |
Unique ID |
Research Team |
June 30, 2022
|
Response to Long COVID: What are the programs or accommodations to current frameworks?
|
EOC220303 RR
|
EOC
|
June 17, 2022
|
What is the evidence on volume of surgery with hip and knee replacements and quality of care?
|
EOC220601 RR
|
EOC
|
May 24, 2022
|
When should post-COVID infected patients receive booster shots?
|
EOC220503 RR
|
EOC
|
May 10, 2022
|
Is there an optimal interval between the administration of COVID-19 early intervention therapeutic products and COVID-19 vaccination?
|
EOC220501 RR
|
EOC
|
March 10, 2022
|
What is the safety/efficacy of the Novavax COVID-19 vaccine?
|
EOC220302 RR
|
EOC
|
February 10, 2022
|
What is the (case) definition of hospitalization for COVID-19 in similar jurisdictions?
|
CAC220101 RR
|
Clinical/Acute Care
|
February 10, 2022
|
What are the latest health policy definitions of being fully vaccinated?
|
EOC220101 RR
|
EOC
|
January 27, 2022
|
What are the roles or function of family caregivers in providing care to other residents in LTC?
|
LTC220101 RR
|
Long Term Care
|
November 30, 2021
|
What are the risks associated with repeated exposure to Ethylene Oxide from ongoing use of the Abbott Panbio AG COVID-19 Nasal swabs?
|
EOC211126 RR
|
EOC
|
October 18, 2021
|
What have been the consequences of delayed surgeries due to the COVID-19 pandemic?
|
EOC210903 RR
|
EOC
|
October 7, 2021
|
What is the current evidence and recommendations regarding COVID-19 vaccine booster shots (exceeding 2 doses) for the general population?
|
EOC210902 RR
|
EOC
|
August 24, 2021
|
What are other jurisdictions offering for incentive-based COVID-19
vaccine campaigns?
|
EOC210501v2 RR
|
EOC
|
June 21, 2021
|
What are the ethical/legal aspects of vaccine requirements?
|
EOC210503 RR
|
EOC
|
June 10, 2021
|
What are legitimate exemptions/contraindications for COVID-19 vaccines from a medical point of view?
|
EOC210502 RR
|
EOC
|
June 9, 2021
|
How has COVID-19 and the public health response to COVID-19 impacted mental health outcomes on children 5 to 18 years (school-age)?
|
PH021701 RR
|
Public Health
|
April 21, 2021
|
What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations?
|
EOC210302 RR
|
EOC
|
April 6, 2021
|
How to deliver remote ICU care for COVID-19 patients to avoid/prevent transfer from smaller communities to tertiary care hospitals
|
CC210301 RR
|
Critical Care
|
March 18, 2021
|
What are the differences between COVID-19 vaccines and how should they be distributed based on population group(s)?
|
EOC031001 RR
|
EOC
|
February 27, 2021
|
What is the final disposition of post-COVID patients who require chronic ventilation in the ICU?
|
CC011101 RR
|
Critical Care
|
February 4, 2021
|
Are there validated clinical prediction tools of which Covid-19 inpatients are most probable to require ICU level care?
|
EOC012001 RR
|
EOC
|